 |
Reverse merger and $18m fundraising with Two River Group/Riverbank at $27m pre-money valuation for Arno Therapeutics. Clinical-stage biopharmaceutical company developing innovative product for the treatment of cancer Press Release
|
|
 |
Reverse merger and $12m fund raising with vFinance at $28m pre-money valuation for Usunco Automotive. Developer and distributor of medium-sized diesel engines from China to customers in China and N America
|
 |
Reverse merger with two subsidiaries of Yongzhen International Marine to form Sino Shipping Holdings Inc. Marine bulk transportation in China and Southeast Asia Press Release
|
|
 |
Reverse merger and $18m fund raising with Rodman & Renshaw at $55m pre-money valuation for Javelin Pharmaceuticals (JAV). Post operative pain management drug development. After follow-on offering has moved up to Amex
|
 |
Reverse merger and subsequent $9m fundraising by China Hand Fund for China New Energy Group. Vertically integrated natural gas distribution to residential and industrial customers in small/medium cities in China Press Release
|
|
 |
Reverse merger and $11m fund raising with Rodman & Renshaw and Roth Capital at $18m pre-money valuation for Osteologix Inc (OLGX). Bone treatment drug development |
 |
Reverse merger and $10m fundraising at $26m pre-money valuation for NovaRay. Subsequent $10m follow-on. Innovative developer of revolutionary digital x-ray technology for medical imaging; enables real-time, low-dose tomographic imaging for cardiac catheterization Press Release
|
|
 |
Reverse merger and $58.5m fund raising with Cowen & Co at $45m pre-money valuation for uBid.com (ENAB). Online market place for computers and electronics |
 |
Reverse merger and $20m fundraising with Two River Group/Riverbank at $43m pre-money valuation for Nile Therapeutics. Clinical-stage biopharmaceutical company developing innovative product for the treatment of cardiovascular disease. Now trading on NASDAQ
|
|
 |
Early stage funding for Vycor Medical, LLC. Highly innovative brain and spine surgery retraction devices. Follow-on funding led by Fountainhead and Regent Private Capital |
 |
$10m private fund raising with Sanders Morris for Active Implants Corporation. Innovative orthopedic implants using pliable materials enabling less invasive surgical methods.
|
|
|
|
